| Literature DB >> 31816959 |
Loredana Colceriu Burtea1, Cristina Prejmerean2, Doina Prodan2, Ioana Baldea3, Mihaela Vlassa2, Miuta Filip2, Marioara Moldovan2, Madalina-Anca Lazar Moldovan4, Aurora Antoniac5, Vasile Prejmerean6, Ioana Ambrosie1.
Abstract
The aim of the present work was to prepare a series of novel restorative giomers and investigate the morphology, the physico-chemical properties (residual monomer, fluoride release), and the cytotoxicity of the new materials. The experimental giomers were prepared as light-cured pastes by blending different resin matrices comprising aromatic/aliphatic/urethane (di) methacrylates, with hybrid fillers containing pre-reacted glasses (PRGs), a radiopaque glass, and nano fluorhydroxyapatite. Polyalkenoic acids based on acrylic acid/itaconic acid/N-acryloyl -L-leucine modified or not with methacrylic groups, together with a superficially active glass, were used to prepare the PRGs. The fluoride ion release of the experimental giomers was investigated within a period of 60 days of storage in bidistilled water while using a fluoride ion selective electrode. Beautifil II commercial product was used as a reference. Cell cytotoxicity tests were done in vitro, in accordance with ISO 10993-122012 proceedings. Human dermal fibroblasts and umbilical endothelial vein cultures were used. The values that were obtained for cumulative fluoride release for all experimental giomers were higher than for the Beautifil II product, being more than twice the ones that were obtained for the commercial product after 60 days of storage in bidistilled water. The experimental biomaterials showed similar and/or better results when compared to the commercial one; this effect was maintained in all tested conditions.Entities:
Keywords: SEM; cytotoxicity; dental giomers; fluoride release; residual monomer
Year: 2019 PMID: 31816959 PMCID: PMC6926637 DOI: 10.3390/ma12234021
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
The composition of the experimental giomer pastes.
| No. | Resin | Hibrid Filler | ||||||
|---|---|---|---|---|---|---|---|---|
| Bis-GMA % | UDMA % | TEGDMA % | HEMA % | PRG1 % | PRG2 % | FHAP % | Radiopaque Glass % | |
| A1 | 14 | – | 6 | – | 16 | – | 8 | 56 |
| B1 | 14 | – | 6 | – | - | 16 | 8 | 56 |
| A2 | 14 | – | – | 6 | 16 | – | 8 | 56 |
| A3 | – | 14 | – | 6 | 16 | – | 8 | 56 |
Figure 1High Performance Liquid Chromatography (HPLC) chromatograms of the standard mixture of monomers (30 μg/mL).
The residual monomer related to the initial amount of the monomer in the sample.
| Sample Code | Bis-GMA % | UDMA % | HEMA % | TEGDMA % |
|---|---|---|---|---|
| A1 | 1.62 ± 0.037 | – | – | 0.61 ± 0.166 |
| B1 | 1.65 ± 0.050 | – | – | 0.69 ± 0.135 |
| A2 | 2.13 ± 0.103 | – | 3.67 ± 0.169 | – |
| A3 | – | 0.83 ± 0.071 | 1.17 ± 0.056 | – |
| Beautifil II | 1.08 ± 0.087 * | – | – | 0.58 ± 0.137 * |
Notes: For the calculation of the unreacted monomer in the case of Beautifil II sample, the composition from “Material Safety Data Sheet” [43] was taken into account (Bis-GMA 7.5% and TEGDMA 5% in the dental product).
The residual monomer related to the weight of the sample.
| Sample Code | Bis-GMA % | UDMA % | HEMA % | TEGDMA % | Total Residual Monomer % |
|---|---|---|---|---|---|
| A1 | 1.13 ± 0.138 | – | – | 0.182 ± 0.019 | 1.312 ± 0.081 |
| B1 | 1.18 ± 0.142 | – | – | 0.204 ± 0.013 | 1.384 ± 0.075 |
| A2 | 1.49 ± 0.146 | – | 1.101 ± 0.057 | – | 2.591 ± 0.182 |
| A3 | – | 0.829 ± 0.122 | 0.352 ± 0.073 | – | 1.181 ± 0.331 |
| Beautifil II | 0.65 ± 0.109 | – | – | 0.114 ± 0.232 | 0.764 ± 0.092 |
Figure 2Cumulative fluoride release of commercial Beautifil II and experimental A1, B1, A2, and A3 giomers.
Figure 3Average cumulative fluoride release of A1, B1, A2, and A3 experimental giomers and of Beautifil II commercial product plotted against time.
Figure 4The flexural strengths of the investigated giomers.
Figure 5Scanning Electron Microscopy (SEM) photomicrographs of (a) A1; (b) B1; (c) A2; (d) A3; and, (e) Beautifil II giomers. Surface morphology (×1000) and fracture image after the flexural test (×2000) in the upper right corner.
Figure 6Comparative viability of fibroblasts exposed to the biomaterial extracts—24 h (a) and—72 h (b); human umbilical endothelial vein cultures (HUVEC) exposed to material extracts—24 h (c); and—72 h (d), respectively. Results are presented as % of the untreated controls absorbance at 490 nm; n = 3, average and SD are shown for each experiment.